Gwenny M. Verstappen

Author

University Medical Center Groningen ORCID

Also Known As

Emilia Bigaeva, G M P J Verstappen, G Verstappen, G. M. Verstappen, G. Verstappen, G.M. Verstappen, Gwenny M P J Verstappen, Gwenny M Verstappen, Gwenny M. P. J. Verstappen, Gwenny M. P. Verstappen

118

Publications

Citations

H-Index

Concepts

All Affiliations

University Medical Center Groningen University of Groningen Queen Mary University of London Bristol-Myers Squibb (United States)Leiden University Medical Center

About

Gwenny M. Verstappen is an author at University Medical Center Groningen specializing in rheumatology, autoimmune disease, and allergy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	238
2	Allergy	3	3	238
3	Immunology	2	2	155
4	Pathology	2	2	155
5	Clinical Immunology	1	1	135

Gwenny M. Verstappen

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Attenuation of Follicular Helper T Cell–Dependent B Cell Hyperactivity by Abatacept Treatment in Primary Sjögren's Syndrome Gwenny M. Verstappen, Petra M. Meiners, Odilia B. J. Corneth, Arthritis & Rheumatology	2017	171
T cells in primary Sjögren’s syndrome: targets for early intervention Gwenny M. Verstappen, Frans G. M. Kroese, Hendrika Bootsma Lara D. Veeken Clinical ImmunologyImmune ActivationLymphocyte DevelopmentAdaptive Immune SystemT-regulatory Cell	2019	135
Enhanced Bruton's Tyrosine Kinase Activity in Peripheral Blood B Lymphocytes From Patients With Autoimmune Disease Odilia B. J. Corneth, Gwenny M. Verstappen, Sandra M. J. Paulissen, Arthritis & Rheumatology	2017	104
The Transcriptome of Paired Major and Minor Salivary Gland Tissue in Patients With Primary Sjögren’s Syndrome Gwenny M. Verstappen, Lu Gao, Sarah Pringle, Frontiers in Immunology	2021	100
Abatacept treatment for patients with early active primary Sjögren's syndrome: a single-centre, randomised, double-blind, placebo-controlled, phase 3 trial (ASAP-III study) Jolien F. van Nimwegen, Esther Mossel, Greetje S. van Zuiden, The Lancet Rheumatology Rheumatoid DisorderRheumatologyAutoimmune DiseaseAllergySjögren’s Syndrome	2020	83
Salivary Gland Stem Cells Age Prematurely in Primary Sjögren's Syndrome Sarah Pringle, Xiaoyan Wang, Gwenny M. Verstappen, Arthritis & Rheumatology	2018	69
Composite of Relevant Endpoints for Sjögren's Syndrome (CRESS): development and validation of a novel outcome measure Suzanne Arends, Liseth de Wolff, Jolien F. van Nimwegen, The Lancet Rheumatology	2021	65
Gene expression profiling of epithelium-associated FcRL4+ B cells in primary Sjögren's syndrome reveals a pathogenic signature Gwenny M. Verstappen, John A. Ice, Hendrika Bootsma, Journal of Autoimmunity	2020	62
B Cell Depletion Therapy Normalizes Circulating Follicular Th Cells in Primary Sjögren Syndrome Gwenny M. Verstappen, Frans G. M. Kroese, Petra M. Meiners, The Journal of Rheumatology	2016	59
Long-term abatacept treatment for 48 weeks in patients with primary Sjögren's syndrome: The open-label extension phase of the ASAP-III trial Liseth de Wolff, Jolien F. van Nimwegen, Esther Mossel, Seminars in Arthritis and Rheumatism	2022	36

Page 1